Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
USS | Ann: USS NTA 30-07-2025 $7.83518 | 08:09 | 0 | 20 | |||
|
|||||||
USS | Ann: USS NTA 29-07-2025 $7.82045 | 30/07/25 | 0 | 36 | |||
|
|||||||
USS | Ann: USS NTA 28-07-2025 $7.81675 | 29/07/25 | 0 | 60 | |||
|
|||||||
USS | Ann: USS NTA 25-07-2025 $7.72313 | 28/07/25 | 0 | 36 | |||
|
|||||||
USS | Ann: USS NTA 24-07-2025 $7.80014 | 25/07/25 | 0 | 79 | |||
|
|||||||
USS | Ann: USS NTA 23-07-2025 $7.78139 | 24/07/25 | 0 | 56 | |||
|
|||||||
USS | Ann: USS NTA 22-07-2025 $7.70251 | 23/07/25 | 0 | 46 | |||
|
|||||||
USS | Ann: USS NTA 21-07-2025 $7.75260 | 22/07/25 | 0 | 59 | |||
|
See All Discussions